Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...

promoting antitumor activity and expansion of memory T cell precursors. HIV infection persists under antiretroviral therapy due to a reservoir of latently infected cells. This Perspective ...

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...

Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...

A mouse study at Memorial Sloan Kettering Cancer Center has found that adding Nef, a protein from HIV, allows donor CAR T cells to avoid detection by the immune system while still attacking tumors.

Pathogen-fighting immune cells called tissue-resident memory CD8 T cells (TRM cells) go through a surprising transformation -- and relocation -- as they fight infections in the small intestine.

2024 — An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study. By targeting infected cells in the brain ...

Determinants of HIV cell tropism & chemokine receptor usage The V3 loop of HIV-1 gp120 is a primary determinant of cell tropism and chemokine receptor usage, whereas the V1/V2 region is involved ...

By combining the Gaiha Lab's expertise in T cell immunology with the Barzilay ... The tool was validated using experimental data from influenza, HIV, and Epstein-Barr virus (EBV) and was able ...